AICAR vs SLU-PP-332: Exercise Mimetic Peptide Research Compared

Exercise mimetics are a class of research compounds studied for their ability to activate the same metabolic signalling pathways triggered by physical exercise — without the exercise itself. AICAR and SLU-PP-332 are two of the most-studied compounds in this space, but they act on entirely different targets.

AICAR: The AMPK Activator

AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) is a cell-permeable nucleotide analog that directly activates AMP-activated protein kinase (AMPK) — the same master energy-sensing pathway triggered by caloric restriction and endurance exercise.

Key research findings on AICAR:

• ·Endurance enhancement — a widely cited 2008 study in Cell found AICAR-treated sedentary mice increased treadmill running distance by roughly 44% without any training
• ·Fatty acid oxidation — AMPK activation shifts cellular metabolism toward burning fat for fuel
• ·Glucose uptake — AICAR stimulates GLUT4 translocation in skeletal muscle independent of insulin signalling, a pathway of interest in insulin resistance research
• ·Mitochondrial biogenesis — chronic AMPK activation upregulates PGC-1α, driving the creation of new mitochondria

SLU-PP-332: The ERR Agonist

SLU-PP-332 is a newer research compound that works through a different route entirely — it's a pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), transcription factors that govern mitochondrial biogenesis and oxidative metabolism gene programs.

Key research findings on SLU-PP-332:

• ·Direct transcriptional activation — rather than triggering an upstream kinase, SLU-PP-332 binds ERRs directly, switching on the genetic programs for mitochondrial density and oxidative fiber type
• ·Running capacity in preclinical models — a 2023 study found SLU-PP-332 increased treadmill endurance and oxidative muscle fiber markers in mice without exercise training
• ·Fiber-type shifting — research suggests SLU-PP-332 promotes a shift toward slow-twitch, fatigue-resistant muscle fiber characteristics
• ·Metabolic rate — ERR activation is associated with increased energy expenditure in preclinical models

Mechanism Comparison

| Feature | AICAR | SLU-PP-332 |

|---|---|---|

| Primary target | AMPK (kinase, upstream signal) | ERRα/β/γ (nuclear receptors, direct transcription) |

| Pathway position | Activates a signalling cascade | Directly switches on gene expression programs |

| Research focus | Endurance, glucose uptake, fat oxidation | Mitochondrial biogenesis, oxidative fiber type |

| Discovery era | 1990s (as an AMPK research tool) | 2020s (purpose-built ERR agonist) |

| Human clinical data | Limited; mostly preclinical | Very limited; early-stage preclinical |

Why Researchers Study Both

Because AICAR and SLU-PP-332 act on different points in the exercise-adaptation cascade — one upstream (AMPK signalling), one downstream (direct transcriptional control) — comparing their effects helps researchers map how much of the "exercise phenotype" can be reproduced through a single pathway versus requiring convergent activation of multiple systems. Some research protocols also examine 5-Amino-1MQ alongside these two compounds; see the AICAR vs SLU-PP-332 vs 5-Amino-1MQ comparison for a three-way breakdown.

Research Considerations

Both compounds remain investigational research chemicals without approved human applications. Preclinical data is promising but based primarily on rodent models; researchers should treat dosing figures from animal studies as a starting reference point for further investigation, not a translated human protocol.

Storage

Both AICAR and SLU-PP-332 should be stored as lyophilized powder at -20°C for long-term stability, reconstituted with bacteriostatic water, and used within the standard 28–30 day refrigerated window once mixed.

Shop AICAR and SLU-PP-332, or browse the Performance category for related metabolic research compounds.

Note: AICAR and SLU-PP-332 are sold strictly for laboratory research use. Not for human consumption.